Triesence
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Triesence, covering 2007-11-29 to 2024-11-20. Get the full timeline:
Most recent: Clinical Trial Update: Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular Edema [Phase 2]